Bulletin
Investor Alert

New York Markets Open in:

press release

Sept. 22, 2021, 9:06 a.m. EDT

Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference

NORTHBROOK, Ill., Sep 22, 2021 (GLOBE NEWSWIRE via COMTEX) -- NORTHBROOK, Ill., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. /zigman2/quotes/223252698/composite CRXT -4.24% , a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present at the 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27, 2021, 10:40 a.m. ET.

The presentation will be webcast live and can be accessed through the Investors section of Clarus Therapeutics' website at Investors.ClarusTherapeutics.com . An archived version of the webcast will be available approximately two hours following the live presentation for 90 days.

About Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women - including potential therapies for orphan indications. Clarus Therapeutics' first commercial product is JATENZO(R). For more information, visit www.clarustherapeutics.com and www.jatenzo.com . Follow us on Twitter ( @Clarus_Thera ) and LinkedIn ( Clarus Therapeutics ).

Clarus Investor Relations Contact:
Kara Stancell
kstancell@clarustherapeutics.com
(847) 562-4300 x 206


COMTEX_393805524/2471/2021-09-22T09:05:44

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/223252698/composite
US : U.S.: Nasdaq
$ 4.52
-0.20 -4.24%
Volume: 476,004
Dec. 8, 2021 4:00p
P/E Ratio
13.50
Dividend Yield
N/A
Market Cap
$102.55 million
Rev. per Employee
N/A
loading...

Partner Center

Link to MarketWatch's Slice.